JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles

Ken Ichiro Ito, Sakuji Shigematsu, Toshiaki Sato, Takako Abe, Yulong Li, Makoto Arita

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

1. A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective. However, the precise mechanism underlying the cardioprotective effect of this drug is unknown. 2. Coronary-perfused guinea-pig ventricular muscles were subjected to 20-min no-flow ischaemia followed by 60-min reperfusion (I/R). I/R significantly decreased the contraction in untreated preparations (control group, 34 ± 4% of baseline value, n = 6). Brief administration of JT (1.0 μM) prior to ischaemia significantly improved the postischaemic contractile recovery (63 ± 5% of baseline value, n = 4), as compared to the control group. 3. JT (1.0 μM) slightly prolonged action potential duration before ischaemia and induced conduction disturbance (2:1 block) after the initiation of ischaemia. 4. The cardioprotective effect of JT was antagonized by chelerythrine (CH, 5.0 μM), an inhibitor of protein kinase C (PKC) or by 5-hydroxydecanoic acid (5-HD, 400 μM), an inhibitor of mitochondrial ATP-sensitive K+ (K(ATP)) channels. 5. These results suggest that the protective effect of JT is due to the opening of mitochondrial K(ATP) channels, which, in turn, is linked to PKC activation.

Original languageEnglish (US)
Pages (from-to)767-776
Number of pages10
JournalBritish Journal of Pharmacology
Volume130
Issue number4
DOIs
StatePublished - Jan 1 2000

Fingerprint

Cardiotonic Agents
Myocardial Reperfusion
Guinea Pigs
Ischemia
Muscles
Protein Kinase C
Adenosine Triphosphate
Control Groups
Action Potentials
Reperfusion
K201 compound
Pharmaceutical Preparations

Keywords

  • Mitochondria
  • Pharmacological preconditioning
  • Protein kinase C

ASJC Scopus subject areas

  • Pharmacology

Cite this

JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles. / Ito, Ken Ichiro; Shigematsu, Sakuji; Sato, Toshiaki; Abe, Takako; Li, Yulong; Arita, Makoto.

In: British Journal of Pharmacology, Vol. 130, No. 4, 01.01.2000, p. 767-776.

Research output: Contribution to journalArticle

@article{2eab4e2297074e6384742434096cc879,
title = "JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles",
abstract = "1. A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective. However, the precise mechanism underlying the cardioprotective effect of this drug is unknown. 2. Coronary-perfused guinea-pig ventricular muscles were subjected to 20-min no-flow ischaemia followed by 60-min reperfusion (I/R). I/R significantly decreased the contraction in untreated preparations (control group, 34 ± 4{\%} of baseline value, n = 6). Brief administration of JT (1.0 μM) prior to ischaemia significantly improved the postischaemic contractile recovery (63 ± 5{\%} of baseline value, n = 4), as compared to the control group. 3. JT (1.0 μM) slightly prolonged action potential duration before ischaemia and induced conduction disturbance (2:1 block) after the initiation of ischaemia. 4. The cardioprotective effect of JT was antagonized by chelerythrine (CH, 5.0 μM), an inhibitor of protein kinase C (PKC) or by 5-hydroxydecanoic acid (5-HD, 400 μM), an inhibitor of mitochondrial ATP-sensitive K+ (K(ATP)) channels. 5. These results suggest that the protective effect of JT is due to the opening of mitochondrial K(ATP) channels, which, in turn, is linked to PKC activation.",
keywords = "Mitochondria, Pharmacological preconditioning, Protein kinase C",
author = "Ito, {Ken Ichiro} and Sakuji Shigematsu and Toshiaki Sato and Takako Abe and Yulong Li and Makoto Arita",
year = "2000",
month = "1",
day = "1",
doi = "10.1038/sj.bjp.0703373",
language = "English (US)",
volume = "130",
pages = "767--776",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles

AU - Ito, Ken Ichiro

AU - Shigematsu, Sakuji

AU - Sato, Toshiaki

AU - Abe, Takako

AU - Li, Yulong

AU - Arita, Makoto

PY - 2000/1/1

Y1 - 2000/1/1

N2 - 1. A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective. However, the precise mechanism underlying the cardioprotective effect of this drug is unknown. 2. Coronary-perfused guinea-pig ventricular muscles were subjected to 20-min no-flow ischaemia followed by 60-min reperfusion (I/R). I/R significantly decreased the contraction in untreated preparations (control group, 34 ± 4% of baseline value, n = 6). Brief administration of JT (1.0 μM) prior to ischaemia significantly improved the postischaemic contractile recovery (63 ± 5% of baseline value, n = 4), as compared to the control group. 3. JT (1.0 μM) slightly prolonged action potential duration before ischaemia and induced conduction disturbance (2:1 block) after the initiation of ischaemia. 4. The cardioprotective effect of JT was antagonized by chelerythrine (CH, 5.0 μM), an inhibitor of protein kinase C (PKC) or by 5-hydroxydecanoic acid (5-HD, 400 μM), an inhibitor of mitochondrial ATP-sensitive K+ (K(ATP)) channels. 5. These results suggest that the protective effect of JT is due to the opening of mitochondrial K(ATP) channels, which, in turn, is linked to PKC activation.

AB - 1. A newly synthesized benzothiazepine derivative, JTV-519 (JT) has been reported to be cardioprotective. However, the precise mechanism underlying the cardioprotective effect of this drug is unknown. 2. Coronary-perfused guinea-pig ventricular muscles were subjected to 20-min no-flow ischaemia followed by 60-min reperfusion (I/R). I/R significantly decreased the contraction in untreated preparations (control group, 34 ± 4% of baseline value, n = 6). Brief administration of JT (1.0 μM) prior to ischaemia significantly improved the postischaemic contractile recovery (63 ± 5% of baseline value, n = 4), as compared to the control group. 3. JT (1.0 μM) slightly prolonged action potential duration before ischaemia and induced conduction disturbance (2:1 block) after the initiation of ischaemia. 4. The cardioprotective effect of JT was antagonized by chelerythrine (CH, 5.0 μM), an inhibitor of protein kinase C (PKC) or by 5-hydroxydecanoic acid (5-HD, 400 μM), an inhibitor of mitochondrial ATP-sensitive K+ (K(ATP)) channels. 5. These results suggest that the protective effect of JT is due to the opening of mitochondrial K(ATP) channels, which, in turn, is linked to PKC activation.

KW - Mitochondria

KW - Pharmacological preconditioning

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=0034082466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034082466&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0703373

DO - 10.1038/sj.bjp.0703373

M3 - Article

VL - 130

SP - 767

EP - 776

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -